David J. Keeling

2.7k total citations · 1 hit paper
73 papers, 2.0k citations indexed

About

David J. Keeling is a scholar working on Molecular Biology, Oncology and Transportation. According to data from OpenAlex, David J. Keeling has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Transportation. Recurrent topics in David J. Keeling's work include ATP Synthase and ATPases Research (23 papers), Ion Transport and Channel Regulation (19 papers) and Drug Transport and Resistance Mechanisms (9 papers). David J. Keeling is often cited by papers focused on ATP Synthase and ATPases Research (23 papers), Ion Transport and Channel Regulation (19 papers) and Drug Transport and Resistance Mechanisms (9 papers). David J. Keeling collaborates with scholars based in United States, United Kingdom and Sweden. David J. Keeling's co-authors include Jan P. Mattsson, Michael E. Parsons, Robert J. Ife, Colin A. Leach, Pia Wallbrandt, Anna Villa, Paul J. Orchard, Paolo Vezzoni, Mario Abinun and Silvia Giliani and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Annals of the New York Academy of Sciences.

In The Last Decade

David J. Keeling

66 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis

2000 503 citations Annalisa Frattini, Paul J. Orchard et al. Nature Genetics profile →

Peers

David J. Keeling

MB

ONCOL

SURGE

OC

GASTR

Paul D. Crowe United States

James M. Collins United States

Chang Lee United States

Stéphane Dion Canada

Judith McKay United Kingdom

Rebecca Shepherd United Kingdom

David L. Emerson United States

Michael D. Thompson United States

Takashi Tsukamoto United States

Tündé Kovàcs Hungary

Paul D. Crowe United States

David J. Keeling

887 ×0.7

MB

376 ×1.1

ONCOL

286 ×0.9

SURGE

120 ×0.5

OC

147 ×0.6

GASTR

Citations per year, relative to David J. Keeling David J. Keeling (= 1×) peers Paul D. Crowe

Countries citing papers authored by David J. Keeling

Since Specialization

Citations

This map shows the geographic impact of David J. Keeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Keeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Keeling more than expected).

Fields of papers citing papers by David J. Keeling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Keeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Keeling. The network helps show where David J. Keeling may publish in the future.

Co-authorship network of co-authors of David J. Keeling

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Keeling. A scholar is included among the top collaborators of David J. Keeling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Keeling. David J. Keeling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Keeling, David J.. (2020). Transport geography in Iceland. Journal of Transport Geography. 89. 102875–102875. 4 indexed citations

2.

Davis, Andrew, et al.. (2005). Components of Successful Lead Generation. Current Topics in Medicinal Chemistry. 5(4). 421–439. 77 indexed citations

3.

Parsons, Michael E. & David J. Keeling. (2005). Novel approaches to the pharmacological blockade of gastric acid secretion. Expert Opinion on Investigational Drugs. 14(4). 411–421. 62 indexed citations

4.

Holman, R., et al.. (2004). El futuro del desarrollo de productos. 9(2). 92–99. 1 indexed citations

5.

Keeling, David J.. (2003). Corporate finance : public companies and the city. 1 indexed citations

6.

Kann, Nina, et al.. (2000). Solid phase synthesis of diamides as potential bone resorption inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(5). 503–507. 4 indexed citations

7.

Frattini, Annalisa, Paul J. Orchard, Cristina Sobacchi, et al.. (2000). Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nature Genetics. 25(3). 343–346. 503 indexed citations breakdown →

8.

Mattsson, Jan P., Sheng‐Bin Peng, Fredrik Nilsson, et al.. (2000). Properties of three isoforms of the 116‐kDa subunit of vacuolar H⁺‐ATPase from a single vertebrate species. European Journal of Biochemistry. 267(13). 4115–4126. 34 indexed citations

9.

Mattsson, Jan P. & David J. Keeling. (1996). [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H+-ATPase. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1280(1). 98–106. 26 indexed citations

10.

Pope, Andrew J., Mark K. Boehm, Colin A. Leach, et al.. (1995). Properties of the reversible, K+-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity. Biochemical Pharmacology. 50(10). 1543–1549. 15 indexed citations

11.

Keeling, David J., et al.. (1995). Pharmacological aspects of acid secretion. Digestive Diseases and Sciences. 40(S2). 3S–23S. 97 indexed citations

12.

Leach, Colin A., Thomas H. Brown, Robert J. Ife, et al.. (1995). Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 4. Identification of an Inhibitor with an Intermediate Duration of Action. Journal of Medicinal Chemistry. 38(14). 2748–2762. 22 indexed citations

13.

Ife, Robert J., Thomas H. Brown, Peter Blurton, et al.. (1995). Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 5. Substituted 2,4-Diaminoquinazolines and Thienopyrimidines. Journal of Medicinal Chemistry. 38(14). 2763–2773. 38 indexed citations

14.

Mattsson, Jan P., Pia Lorentzon, B. Wallmark, & David J. Keeling. (1993). Characterization of proton transport in bone-derived membrane vesicles. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1146(1). 106–112. 23 indexed citations

15.

Helander, Herbert F. & David J. Keeling. (1993). Cell biology of gastric acid secretion. Baillière s Clinical Gastroenterology. 7(1). 1–21. 30 indexed citations

16.

Leach, Colin A., Thomas H. Brown, David J. Keeling, et al.. (1992). Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent. Journal of Medicinal Chemistry. 35(10). 1845–1852. 49 indexed citations

17.

Ife, Robert J., Thomas H. Brown, David J. Keeling, et al.. (1992). Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-Substituted-4-(phenylamino)quinolines. Journal of Medicinal Chemistry. 35(18). 3413–3422. 40 indexed citations

18.

Keeling, David J., et al.. (1991). Effects of NPPB (5-nitro-2-(3-phenylpropylamino)benzoic acid) on chloride transport in intestinal tissues and the T84 cell line. Biochimica et Biophysica Acta (BBA) - General Subjects. 1115(1). 42–48. 23 indexed citations

19.

Keeling, David J., et al.. (1991). SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase. Biochemical Pharmacology. 42(1). 123–130. 45 indexed citations

20.

Simon, Wolfgang, et al.. (1990). By 1023/SK&F 96022: Biochemistry of a novel (H+ + K+-ATPase inhibitor. Biochemical Pharmacology. 39(11). 1799–1806. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact